107 related articles for article (PubMed ID: 32263681)
1. Glyco-decorated tobacco mosaic virus as a vector for cisplatin delivery.
Liu X; Liu B; Gao S; Wang Z; Tian Y; Wu M; Jiang S; Niu Z
J Mater Chem B; 2017 Mar; 5(11):2078-2085. PubMed ID: 32263681
[TBL] [Abstract][Full Text] [Related]
2. Tobacco Mosaic Virus-Based 1D Nanorod-Drug Carrier via the Integrin-Mediated Endocytosis Pathway.
Tian Y; Gao S; Wu M; Liu X; Qiao J; Zhou Q; Jiang S; Niu Z
ACS Appl Mater Interfaces; 2016 May; 8(17):10800-7. PubMed ID: 27062971
[TBL] [Abstract][Full Text] [Related]
3. Featured Article: Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles.
Kernan DL; Wen AM; Pitek AS; Steinmetz NF
Exp Biol Med (Maywood); 2017 Aug; 242(14):1405-1411. PubMed ID: 28675044
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-Loaded Tobacco Mosaic Virus for Ovarian Cancer Treatment.
Zhao Z; Simms A; Steinmetz NF
Biomacromolecules; 2022 Oct; 23(10):4379-4387. PubMed ID: 36053908
[TBL] [Abstract][Full Text] [Related]
5. Tobacco Mosaic Virus-Delivered Cisplatin Restores Efficacy in Platinum-Resistant Ovarian Cancer Cells.
Franke CE; Czapar AE; Patel RB; Steinmetz NF
Mol Pharm; 2018 Aug; 15(8):2922-2931. PubMed ID: 28926265
[TBL] [Abstract][Full Text] [Related]
6. Tobacco Mosaic Virus with Peroxidase-Like Activity for Cancer Cell Detection through Colorimetric Assay.
Guo J; Zhao X; Hu J; Lin Y; Wang Q
Mol Pharm; 2018 Aug; 15(8):2946-2953. PubMed ID: 29300485
[TBL] [Abstract][Full Text] [Related]
7. Tobacco mosaic virus delivery of mitoxantrone for cancer therapy.
Lin RD; Steinmetz NF
Nanoscale; 2018 Aug; 10(34):16307-16313. PubMed ID: 30129956
[TBL] [Abstract][Full Text] [Related]
8. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles.
Pitek AS; Hu H; Shukla S; Steinmetz NF
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39468-39477. PubMed ID: 30403330
[TBL] [Abstract][Full Text] [Related]
9. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.
Quan G; Pan X; Wang Z; Wu Q; Li G; Dian L; Chen B; Wu C
J Nanobiotechnology; 2015 Feb; 13():7. PubMed ID: 25643602
[TBL] [Abstract][Full Text] [Related]
10. Tobacco mosaic virus for the targeted delivery of drugs to cells expressing prostate-specific membrane antigen.
Shukla S; Marks I; Church D; Chan SK; Pokorski JK; Steinmetz NF
RSC Adv; 2021 Jun; 11(33):20101-20108. PubMed ID: 34178308
[TBL] [Abstract][Full Text] [Related]
11. ORF6 of Tobacco mosaic virus is a determinant of viral pathogenicity in Nicotiana benthamiana.
Canto T; MacFarlane SA; Palukaitis P
J Gen Virol; 2004 Oct; 85(Pt 10):3123-3133. PubMed ID: 15448376
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors.
Petukhova NV; Gasanova TV; Stepanova LA; Rusova OA; Potapchuk MV; Korotkov AV; Skurat EV; Tsybalova LM; Kiselev OI; Ivanov PA; Atabekov JG
Curr Pharm Des; 2013; 19(31):5587-600. PubMed ID: 23394564
[TBL] [Abstract][Full Text] [Related]
13. Elongated Plant Virus-Based Nanoparticles for Enhanced Delivery of Thrombolytic Therapies.
Pitek AS; Wang Y; Gulati S; Gao H; Stewart PL; Simon DI; Steinmetz NF
Mol Pharm; 2017 Nov; 14(11):3815-3823. PubMed ID: 28881141
[TBL] [Abstract][Full Text] [Related]
14. Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer.
Bruckman MA; Czapar AE; VanMeter A; Randolph LN; Steinmetz NF
J Control Release; 2016 Jun; 231():103-13. PubMed ID: 26941034
[TBL] [Abstract][Full Text] [Related]
15. High-efficiency protein expression in plants from agroinfection-compatible Tobacco mosaic virus expression vectors.
Lindbo JA
BMC Biotechnol; 2007 Aug; 7():52. PubMed ID: 17723150
[TBL] [Abstract][Full Text] [Related]
16. Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy.
Czapar AE; Zheng YR; Riddell IA; Shukla S; Awuah SG; Lippard SJ; Steinmetz NF
ACS Nano; 2016 Apr; 10(4):4119-26. PubMed ID: 26982250
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis.
Li M; Tang Z; Zhang Y; Lv S; Li Q; Chen X
Acta Biomater; 2015 May; 18():132-43. PubMed ID: 25735801
[TBL] [Abstract][Full Text] [Related]
18. Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.
Banik S; Mansour AA; Suresh RV; Wykoff-Clary S; Malik M; McCormick AA; Bakshi CS
PLoS One; 2015; 10(6):e0130858. PubMed ID: 26098553
[TBL] [Abstract][Full Text] [Related]
19. Molecularly imprinted polymers for tobacco mosaic virus recognition.
Bolisay LD; Culver JN; Kofinas P
Biomaterials; 2006 Aug; 27(22):4165-8. PubMed ID: 16574216
[TBL] [Abstract][Full Text] [Related]
20. Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector.
Pérez-Filgueira DM; Brayfield BP; Phiri S; Borca MV; Wood C; Morris TJ
J Virol Methods; 2004 Nov; 121(2):201-8. PubMed ID: 15381357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
